{"organizations": [], "uuid": "d21dd9f59b73eaa270e6e3d78cc1bf8eba94aa8e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "http://si.wsj.net/public/resources/images/BN-KN415_0928al_G_20150928173314.jpg", "site_section": "http://www.wsj.com/news/business", "section_title": "Business &amp; Finance News - Wall Street Journal", "url": "http://www.wsj.com/articles/allergan-sees-10-rise-in-branded-revenue-1443475521", "country": "US", "title": "Allergan Sees 10% Rise in Branded Revenue", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "Allergan Sees 10% Rise in Branded Revenue - WSJ", "spam_score": 0.0, "site_type": "news", "published": "2015-09-29T01:25:00.000+03:00", "replies_count": 0, "uuid": "d21dd9f59b73eaa270e6e3d78cc1bf8eba94aa8e"}, "author": "Maria Armental", "url": "http://www.wsj.com/articles/allergan-sees-10-rise-in-branded-revenue-1443475521", "ord_in_thread": 0, "title": "Allergan Sees 10% Rise in Branded Revenue", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Allergan PLC updated its financial projections for the second half of the year and said it expects its branded revenue to increase 10% following the sale of its generics unit to Teva Pharmaceutical Industries Ltd.\nDublin-based Allergan in its current form became one of the top-10 drug companies by sales when Actavis bought Allergan, the maker of wrinkle treatment Botox, for nearly $70 billion. Three months later, Actavis changed its... To Read the Full Story, Subscribe or Sign In", "external_links": [], "published": "2015-09-29T01:25:00.000+03:00", "crawled": "2015-09-29T01:01:46.138+03:00", "highlightTitle": ""}